Ebola: Difference between revisions
Rim Halaby (talk | contribs) |
No edit summary |
||
| (12 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ebola}} | {{Ebola}}{{About1|Ebola virus}} | ||
'''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' | '''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' | ||
{{CMG}}; {{AE}} {{MJM}}, {{GRN}}, {{ | {{CMG}}; {{AE}} {{MJM}}, {{GRN}}, {{Marjan}} {{HK}} | ||
{{SK}} Ebola hemorrhagic fever, Ebola haemorrhagic fever, Ebola HF, EHF, Zaire virus, Zaire Ebolavirus, ZEBOV, Sudan Ebolavirus, SEBOV, Reston Ebolavirus, REBOV, Cote d'Ivoire Ebolavirus, CIEBOV, Bundibugyo ebolavirus, Tai Forest ebolavirus | {{SK}} Ebola hemorrhagic fever, Ebola haemorrhagic fever, Ebola HF, EHF, Zaire virus, Zaire Ebolavirus, ZEBOV, Sudan Ebolavirus, SEBOV, Reston Ebolavirus, REBOV, Cote d'Ivoire Ebolavirus, CIEBOV, Bundibugyo ebolavirus, Tai Forest ebolavirus | ||
| Line 22: | Line 22: | ||
==[[Ebola risk factors|Risk Factors]]== | ==[[Ebola risk factors|Risk Factors]]== | ||
==[[Ebola screening|Screening]]== | |||
==[[Ebola natural history|Natural History, Complications and Prognosis]]== | ==[[Ebola natural history|Natural History, Complications and Prognosis]]== | ||
| Line 27: | Line 29: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Ebola | [[Ebola algorithm for the evaluation of the returned traveler|Algorithm for the Evaluation of the Returned Traveler]] | [[Ebola emergency department evaluation|Emergency Department Evaluation]] | [[Ebola case definition|Case Definition]] | [[Ebola history and symptoms|History and Symptoms]] | [[Ebola physical examination|Physical Examination]] | [[Ebola laboratory tests|Laboratory Findings]] | [[Ebola other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Ebola medical therapy|Medical Therapy]] | [[Ebola primary prevention|Primary Prevention]] | [[Ebola future or investigational therapies|Future or Investigational Therapies]] | [[Ebola medical therapy|Medical Therapy]] | [[Ebola air medical transport|Air Medical Transport]] | [[Ebola monitoring and movement of persons following exposure|Monitoring and Movement Following Exposure]] | [[Ebola primary prevention|Primary Prevention]] | [[Ebola future or investigational therapies|Future or Investigational Therapies]] | ||
==Postmortem Care== | ==Postmortem Care== | ||
[[Ebola postmortem care|Postmortem Care]] | [[Ebola postmortem care|Postmortem Care]] | ||
| Line 49: | Line 44: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hemorrhagic fevers]] | [[Category:Hemorrhagic fevers]] | ||
[[Category:Mononegavirales]] | [[Category:Mononegavirales]] | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Zoonoses]] | [[Category:Zoonoses]] | ||
Latest revision as of 13:50, 12 June 2020
|
Ebola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Postmortem Care |
|
Case Studies |
|
Ebola On the Web |
|
American Roentgen Ray Society Images of Ebola |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Guillermo Rodriguez Nava, M.D. [2], Marjan Khan M.B.B.S.[3] Syed Hassan A. Kazmi BSc, MD [4]
Synonyms and keywords: Ebola hemorrhagic fever, Ebola haemorrhagic fever, Ebola HF, EHF, Zaire virus, Zaire Ebolavirus, ZEBOV, Sudan Ebolavirus, SEBOV, Reston Ebolavirus, REBOV, Cote d'Ivoire Ebolavirus, CIEBOV, Bundibugyo ebolavirus, Tai Forest ebolavirus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ebola from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Algorithm for the Evaluation of the Returned Traveler | Emergency Department Evaluation | Case Definition | History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Air Medical Transport | Monitoring and Movement Following Exposure | Primary Prevention | Future or Investigational Therapies